New COVID Variant Symptoms: Cicada BA.3.2 in 2026

If you’ve spotted headlines about a new COVID “Cicada” variant and wondering whether you need to pay attention, you’re not alone. Health trackers have flagged the BA.3.2 strain as one to watch in 2026, and while symptoms mirror what we’ve seen with Omicron relatives, small differences in what the CDC calls an “early detection” warrant a closer look. This guide walks through what the Cicada variant actually feels like, how long it tends to last, and what official bodies are saying about the spread right now.

Detected in: 23 countries ·
Common symptoms: Fever, cough, fatigue ·
Typical duration: 7–10 days

What are the main symptoms of the newest COVID?

The Cicada variant does not introduce unfamiliar symptoms. According to Stony Brook Medicine (medical center tracking variant developments), the BA.3.2 strain sits squarely within the Omicron family and produces the same core picture as its siblings.

Common symptoms

The most frequently reported signs center on the upper respiratory tract. Health sources consistently flag fever, dry cough, and pronounced fatigue as the dominant trio. Sore throat, nasal congestion, and headache round out the typical experience. Body aches can accompany the fever in some cases.

• Fever or chills
• Dry cough
• Fatigue and weakness
• Sore throat
• Nasal congestion or runny nose
• Headache
• Body aches

The Priority Care Clinics notes that recent Omicron subvariants also frequently produce shortness of breath, nausea, and reduced appetite. Brain fog—a murkiness in concentration—is reported by some patients but remains less universal.

Unusual symptoms

Recent Omicron iterations show more cold-like behavior than the Alpha or Delta strains. The Ubie Health (clinical symptom database) points out that runny nose and sneezing appear more often now, and loss of taste or smell has become less common compared to earlier variants.

Sneezing, in particular, registers as a more frequent symptom with current subvariants than it did in prior pandemic years. Gastrointestinal signals like nausea and diarrhea occur in a subset of cases but do not dominate the clinical picture.

The CDC documented early detection of the BA.3.2 variant through its Morbidity and Mortality Weekly Report (MMWR), though the agency tracks spread patterns rather than flagging any novel symptom presentations.

How long does the latest COVID usually last?

For most people with a healthy immune response, COVID-19—including the Cicada variant—clears within 7 to 10 days of symptom onset. The Ubie Health (health technology platform with clinical advisory) notes that Omicron sublineages tend to run their course faster than Delta did, with milder respiratory distress overall.

Typical duration

The timeline breaks roughly as follows: incubation lasts 2 to 4 days after exposure, symptoms peak around days 3 through 5, and most adults feel substantially better by day 7 or 8. Children and immunocompromised individuals may extend that window. Full resolution of cough or lingering fatigue can stretch toward day 10 or beyond without signaling anything abnormal.

Recovery factors

Adequate rest, hydration, and symptom management with over-the-counter fever reducers form the core recovery protocol. Priority Care Clinics (urgent care provider) advises seeking medical evaluation if fever persists beyond five days, if breathing difficulty worsens, or if existing health conditions flare unexpectedly.

The Doral Health & Wellness (health system tracking 2026 variant landscape) observes that 2026 variants are not proving more severe overall, though ongoing management vigilance remains warranted for vulnerable populations.

The implication: most adults recover at home without complications, but the window of feeling genuinely well again often stretches past the point where people expect to be “back to normal.”

How long are you contagious with the newest strain of COVID?

The contagion window for Omicron-related variants—including BA.3.2—typically spans 5 to 10 days after symptoms begin. Ubie Health explains that infectivity generally runs highest in the first few days when viral load peaks.

Contagious period

Current public health guidance aligns with the 5-to-10-day window: most adults are no longer contagious once fever has resolved for at least 24 hours without fever-reducing medication and symptoms show consistent improvement. The risk drops sharply after day 5 for people with mild cases, though (cough) alone beyond day 7 does not necessarily indicate ongoing contagion.

Testing guidance

Rapid antigen tests remain the practical tool for gauging when contagion risk subsides. A negative rapid test on day 5 and again 24 hours later provides reasonable confidence that someone has moved past the peak infectious window. PCR tests, which detect viral fragments longer, are not the right yardstick for “am I still contagious” decisions.

What this means: the instinct to isolate fully through day 10 is clinically sound. Ending isolation earlier than day 5 without symptom improvement is not advisable, regardless of how mild someone feels.

Is there a new strain of COVID going around?

Yes—the BA.3.2 “Cicada” variant has entered circulation globally and is drawing attention from health authorities worldwide. The CDC MMWR documented early detection of this SARS-CoV-2 sublineage, and monitoring continues across multiple countries.

Cicada BA 3.2 details

BA.3.2 carries the “Cicada” nickname—a reference to the 2026 year in which it gained traction, not to any biological connection with cicada insects. Stony Brook Medicine confirms that the variant is being tracked for mutations and geographic spread rather than for any alarming symptom departures.

The strain falls within the Omicron lineage, sharing structural characteristics with XBB.1.5 and related subvariants. Vaccine Advisor (immunization news outlet) notes that BA.3.2 symptoms align closely with NB.1.8.1, another 2026 Omicron derivative circulating concurrently.

Spread in Ireland

Health officials in Ireland reported a surge in BA.3.2 cases beginning in late March 2026. The rise mirrors patterns seen across Europe, where the variant has been detected in 23 countries total. Stony Brook Medicine confirms there is no data suggesting the Irish cicada variant differs from the global strain in transmissibility or severity.

How can I tell if I have COVID or a cold?

Symptom overlap between a mild Omicron infection and a common cold is substantial, which is why testing remains the only reliable differentiator. Priority Care Clinics (urgent care provider) outlines the key contrasts that merit a test.

Key differences

COVID-19 more often starts gradually—a scratchy throat one day, a mild headache the next—before symptoms fully materialize. The Ubie Health (clinical platform with symptom data) notes that sore throat and prolonged fatigue cluster more tightly with COVID than with typical rhinovirus colds. Flu, by contrast, tends to arrive suddenly with high fever and muscle aches.

• COVID: gradual onset, sore throat, prolonged fatigue, reduced taste/smell (less common now), cold-like upper respiratory symptoms
• Flu: sudden onset, high fever, prominent body aches, headache, typically resolves faster than COVID
• Cold: gradual onset, dominated by nasal congestion and sore throat, minimal fever, less fatigue

When to test

Testing is the most reliable path to a definitive answer. Home rapid tests work well when someone is symptomatic. A PCR test through a clinic or testing site offers higher sensitivity and is preferable if exposure is known but symptoms have not yet appeared.

The trade-off: cold-like symptoms alone do not rule COVID in or out. Anyone with known exposure, immunocompromised household members, or upcoming visits to vulnerable populations should test regardless of how “just a cold” the symptoms feel.

Related reading

• How Long Does Gastroenteritis Last – Duration, Symptoms & Recovery
• How to Get Rid of Piles – Natural Remedies and Treatments

For most people, the Cicada BA.3.2 variant is a manageable at-home illness that follows the familiar Omicron playbook: rest, fluids, isolation while symptomatic, and a test before resuming contact with vulnerable people. Health authorities have not flagged this strain as a severe departure from what we’ve already learned to handle. The gap that remains is how well existing vaccines hold up against BA.3.2 specifically—and that question is still open.

The Cicada BA.3.2 variant prompts familiar symptoms like fever and fatigue, while BA.3.2 strain details highlights its global emergence since late 2024.

Frequently asked questions